Ayala Pharmaceuticals, Inc.

ADXSOTCHealthcare

$0.60

+$0.00(+0.00%)

Market Cap$25707577

P/E Ratio—

52W High$0.801

52W Low$0.0011

Avg Volume5K

Open$0.10

Beta-4.03

Overview

Ayala Pharmaceuticals, Inc. (ADXS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ADXS · as of Apr 16, 2024

Latest filing snapshot

+6+40.00%vs prior year

Ayala Pharmaceuticals, Inc. (ADXS) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+40.00%

Revenue / Employee

$619

Net Income / Employee

$-2.29M

Market Cap

$26M

ADXS Employee Count

2009 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-04-16	2023-12-31	21	+6	+40.00%
2023-02-10	2022-10-31	15	+0	+0.00%
2022-02-14	2021-10-31	15	-3	-16.67%
2021-01-22	2020-10-31	18	-17	-48.57%
2019-12-20	2019-10-31	35	-23	-39.66%
2019-01-11	2018-10-31	58	-50	-46.30%
2017-12-21	2017-10-31	108	+18	+20.00%
2017-01-09	2016-10-31	90	+42	+87.50%
2016-01-08	2015-10-31	48	+28	+140.00%
2015-01-06	2014-10-31	20	+3	+17.65%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ADXS

Ayala Pharmaceuticals, Inc.YOU

21$26M

APLIF

Appili Therapeutics Inc.

8$2M

IBOGF

Universal Ibogaine Inc.

7$10M

AAGH

America Great Health

5$4M

AGNPF

Algernon Pharmaceuticals Inc.

5$2M

AGTX

Agentix Corp.

3$1M

HESG

Health Sciences Group, Inc.

2$2M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ADXS peer comparison

About ADXS employees

ADXS Employees · Headcount

Ayala Pharmaceuticals, Inc. (ADXS) employee data is sourced from the annual SEC 10-K filing. As of 2023, Ayala Pharmaceuticals, Inc. had 21 full-time employees globally. Full-time employees only. Global consolidated headcount.

Ayala Pharmaceuticals, Inc. employs 21 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $619, reflecting the company's operational efficiency.

Ayala Pharmaceuticals, Inc.'s workforce increased by 6 (40.00%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Ayala Pharmaceuticals, Inc.'s revenue per employee of $619 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ADXS Employees · 5 questions

As of the latest SEC 10-K filing (2023), Ayala Pharmaceuticals, Inc. had 21 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Ayala Pharmaceuticals, Inc. employee counthow many employees does Ayala Pharmaceuticals, Inc. haveADXS total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-04-16